Drug Profile
Research programme: drug discovery - Actelion
Alternative Names: Actelion-4; Actelion-5; Actelion-6; Actelion-7Latest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator Actelion Pharmaceuticals
- Class
- Mechanism of Action Aspartic endopeptidase modulators; Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Cardiovascular disorders; CNS disorders; Immunological disorders; Infections
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for research development in Cancer in Switzerland
- 28 Feb 2021 No recent reports of development identified for research development in Infections in Switzerland
- 28 Feb 2019 No recent reports of development identified for preclinical development in Cardiovascular-disorders in Switzerland (PO, Capsule)